Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients.

Inkaya, Ahmet Çagkan; Kara, Emre; Basaran, Nursel Çalik; Sahin, Taha Koray; Uyaroglu, Oguz Abdullah; Uzun, Ömrüm; Ünal, Serhat

Inkaya, Ahmet Çagkan; Kara, Emre; Basaran, Nursel Çalik; Sahin, Taha Koray; Uyaroglu, Oguz Abdullah; Uzun, Ömrüm; Ünal, Serhat.

Afiliación

Inkaya AÇ; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kara E; Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Basaran NÇ; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Sahin TK; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Uyaroglu OA; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Uzun Ö; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ünal S; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Turk J Med Sci ; 51(5): 2786-2788, 2021 Oct.

Article en En | MEDLINE | ID: mdl-34392669

Asunto(s)

Tratamiento Farmacológico de COVID-19; Gripe Humana; Humanos; Ácido Úrico; Hipoxantina Fosforribosiltransferasa; SARS-CoV-2; Biomarcadores

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Gripe Humana / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Turk J Med Sci Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google